sábado, 6 de febrero de 2021

FDA grants accelerated approval to umbralisib for marginal zone lymphoma and follicular lymphoma | FDA

FDA grants accelerated approval to umbralisib for marginal zone lymphoma and follicular lymphoma | FDA

No hay comentarios:

Publicar un comentario